Recombinant Growth Hormone
Investigational oral therapy increases height velocity for children with GH deficiency
An oral medication under investigation for treating pediatric GH deficiency boosted annualized height velocity at 6 and 12 months for children, according to topline results from two phase 2 trials.
Researchers propose diagnostic criteria for drug-induced intracranial hypertension
Common medications to treat acne and other inflammatory dermatoses strongly associated with drug-induced intracranial hypertension include vitamin A derivatives, tetracycline-class antibiotics, recombinant growth hormone and lithium, according to a literature review to help guide dermatologists in a diagnostic and drug-causality algorithm.
Combination therapy may boost height for girls with central precocious puberty
Chinese girls diagnosed with central precocious puberty achieved greater gains in total height when treated with combination gonadotropin-releasing hormone analogues, or GnRHa, plus recombinant growth hormone therapy, or rhGH, with low predicted adult height and greater bone age predicting greater success with treatment, according to findings published in The Journal of Clinical Endocrinology & Metabolism.